HOME >> MEDICINE >> NEWS
Positive Results Of Pivotal Phase III Trial With ENBREL In Patients With Early, Active Rheumatoid Arthritis

Immunex Plans To File With The FDA Seeking An Expanded Label For ENBREL To Slow Structural Joint Damage In Patients And to Improve The Signs And Symptoms Of Patients With Early, Active RA

SEATTLE - In patients with early, active rheumatoid arthritis (RA), the primary endpoints from a Phase III study showed that ENBREL® (etanercept) slowed the progression of the disease and reduced the signs and symptoms. ENBREL was found to be generally well tolerated in this clinical trial. This announcement was made today by Immunex Corporation (NASDAQ: IMNX) and Wyeth Ayerst, a division of American Home Products Corporation (NYSE: AHP), the two companies that are co-marketing ENBREL in North America.

Detailed data regarding this clinical trial with a more complete analysis will be presented at a medical meeting in the future. The results described herein are based on investigational data analyzed by Immunex. These data have not been reviewed by the U.S. Food and Drug Administration (FDA) as part of an application for regulatory approval.

"The completion of this major study represents another significant milestone in the development of ENBREL," said Peggy V. Phillips, senior vice president, pharmaceutical development, Immunex. "Based on the positive results of this study, Immunex intends to file a new supplemental biologics license application with the FDA seeking an expanded label for ENBREL to slow structural joint damage in patients with active RA and to improve the signs and symptoms of patients with early, active RA."

The Phase III pivotal study evaluated 633 RA patients with early, active disease who received ENBREL or methotrexate, using two primary endpoints:

  1. To study the ability of ENBREL to slow the progression of RA, the study utilized digitized x-ray data evaluation to monitor changes in joints. Structural damage to joints was measured over a one-year period using the Modified Sharp Sco
    '"/>


Contact: Tim Warner
warnert@immunex.com
206-470-4193
Immunex Corporation
10-May-1999


Page: 1 2 3 4

Related medicine news :

1. Positive mental attitude does not affect cancer survival
2. Positive outlook, sense of self-control can predict new coronary events, says Carnegie Mellon study
3. Anal Cancer Screening For HIV-Positive Gay And Bisexual Men Would Save Lives And Be Cost Effective, New Study Shows
4. Abgenix Reports Positive Survival Data From A Phase II Trial Of ABX-CBL In Graft Versus Host Disease
5. Signal Pharmaceuticals Announces Positive Results In Preclinical Study Of Novel Drug Leads For Treatment Of Osteoporosis
6. UCSF Study Finds Drug Treatment Can Be Cost Effective In Tanzania And Thailand For HIV-Positive Pregnant Women
7. Only Eight Percent Of San Francisco HIV-Positive Urban Poor Receive Protease Inhibitors
8. Cost-Effective Treatment Possible In Africa For HIV-Positive Pregnant Women If Drug Prices Lowered
9. Program Provides Treatment For Prison-Released HIV-Positive Women
10. Heart transplant survival: Results may be key to rejection prevention, detection, treatment
11. Docetaxel versus paclitaxel in breast cancer Results of worlds first head to head trial

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2021)... , ... March 29, 2021 , ... ... the 21st Century , A Virtual Workshop Presented by WCG FDAnews and Cerulean ... 4:30 pm EDT, https://wcg.swoogo.com/modern-sop-and-quality-systems , Are one’s SOPs written for the ...
(Date:3/30/2021)... ... March 29, 2021 , ... According to data released ... reproductive age (13-44) in need of publicly funded contraception live in counties impacted by ... Colorado’s 64 counties have lost some of their Title X resources. , The ...
(Date:3/30/2021)... ... March 29, 2021 , ... Health Literacy Innovations (HLI), a ... confusion due to low health literacy today announces a new partnership with the ... work with ACAP’s member Safety Net Health Plans, those that provide comprehensive health ...
(Date:3/30/2021)... ... ... Dr. Colin Campbell is proud to announce the 1 year anniversary in their new state ... internal medicine and is a primary care specialist who has been practicing for 23 years. ... keep South Jersey healthy one patient at a time. , “Over the past year, Dr. ...
(Date:3/30/2021)... ... March 30, 2021 , ... The COVID-19 ... and survivors; their families; and their caregivers. Crossroads4Hope is addressing the needs of ... emotional support system, MyGo2Support, which meets needs of people impacted by cancer, no ...
Breaking Medicine News(10 mins):
(Date:3/30/2021)... ... March 29, 2021 , ... The University of Texas Health Science Center ... San Antonio Multispecialty and Research Hospital, a destination center for research and treatment of ... In a nod to the COVID-19 pandemic, the ceremony was held virtually. , William ...
(Date:3/30/2021)... ... March 29, 2021 , ... Iora Health ... primary care, has partnered with Devoted Health , one of the fastest-growing ... across Maricopa County and provides seniors with the highest-quality care and experience possible, ...
(Date:3/30/2021)... CITY (PRWEB) , ... March 29, 2021 , ... ... has joined the Vaccine Credential Initiative (VCI), a group bringing together leading health ... record of vaccination status, based on open, interoperable standards. By joining the VCI ...
Breaking Medicine Technology:
Cached News: